Search Results - "ALTON, Kevin B"

Refine Results
  1. 1

    Intestinal lymphatic transport for drug delivery by Yáñez, Jaime A., Wang, Stephen W.J., Knemeyer, Ian W., Wirth, Mark A., Alton, Kevin B.

    Published in Advanced drug delivery reviews (10-09-2011)
    “…Intestinal lymphatic transport has been shown to be an absorptive pathway following oral administration of lipids and an increasing number of lipophilic drugs,…”
    Get full text
    Journal Article
  2. 2

    Application of mass spectrometry for metabolite identification by Ma, Shuguang, Chowdhury, Swapan K, Alton, Kevin B

    Published in Current drug metabolism (01-07-2006)
    “…Metabolism studies play a pivotal role in drug discovery and development. Characterization of metabolic "hot-spots" as well as reactive and pharmacologically…”
    Get more information
    Journal Article
  3. 3

    Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor by GHOSAL, Anima, YUAN YUAN, WEI TONG, SU, Ai-Duen, CHUNYAN GU, CHOWDHURY, Swapan K, KISHNANI, Narendra S, ALTON, Kevin B

    Published in Drug metabolism and disposition (01-03-2011)
    “…Boceprevir (SCH 503034), a protease inhibitor, is under clinical development for the treatment of human hepatitis C virus infections. In human liver…”
    Get full text
    Journal Article
  4. 4

    Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 by Van Heek, Margaret, Farley, Constance, Compton, Douglas S, Hoos, Lizbeth, Alton, Kevin B, Sybertz, Edmund J, Davis, Harry R

    Published in British journal of pharmacology (01-04-2000)
    “…Previous studies described the metabolism‐based discovery of a potent, selective inhibitor of intestinal absorption of cholesterol, SCH58235 (Ezetimibe). Here…”
    Get full text
    Journal Article
  5. 5

    Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects by PATRICK, James E, KOSOGLOU, Teddy, CAYEN, Mitchell N, STAUBER, Kathe L, ALTON, Kevin B, MAXWELL, Stephen E, YALI ZHU, STATKEVICH, Paul, IANNUCCI, Robert, CHOWDHURY, Swapan, AFFRIME, Melton

    Published in Drug metabolism and disposition (01-04-2002)
    “…Ezetimibe [SCH 58235; 1-(4-fluorophenyl)-3( R )-[3-(4-fluorophenyl)-3( S )-hydroxypropyl]-4( S )-(4-hydroxyphenyl)-2-azetidinone], a selective cholesterol…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Identification of Human Liver Cytochrome P450 Enzymes Involved in Biotransformation of Vicriviroc, a CCR5 Receptor Antagonist by GHOSAL, Anima, RAMANATHAN, Ragu, YUAN YUAN, HAPANGAMA, Neil, CHOWDHURY, Swapan K, KISHNANI, Narendra S, ALTON, Kevin B

    Published in Drug metabolism and disposition (01-12-2007)
    “…Vicriviroc (SCH 417690), a CCR5 receptor antagonist, is currently under investigation for the treatment of human immunodeficiency virus infection. The…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A comprehensive investigation of the variable overcontact system EH Cancri by Alton, Kevin B., Nelson, Robert H., Stȩpień, Kazimierz

    Published in Journal of astrophysics and astronomy (01-12-2020)
    “…Precise multi-color CCD-derived photometric data were obtained from EH Cnc at two sites during 2010, 2014 and 2018 wherein each epoch used a different…”
    Get full text
    Journal Article
  10. 10

    Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions by KOSOGLOU, Teddy, STATKEVICH, Paul, JOHNSON-LEVONAS, Amy O, PAOLINI, John F, BERGMAN, Arthur J, ALTON, Kevin B

    Published in Clinical pharmacokinetics (01-01-2005)
    “…Ezetimibe is the first lipid-lowering drug that inhibits intestinal uptake of dietary and biliary cholesterol without affecting the absorption of fat-soluble…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Response Normalized Liquid Chromatography Nanospray Ionization Mass Spectrometry by Ramanathan, Ragu, Zhong, Ruyun, Blumenkrantz, Neil, Chowdhury, Swapan K., Alton, Kevin B.

    “…The widely different LC-MS response observed for many structurally different compounds limits the use of LC-MS in full scan detection mode for quantitative…”
    Get full text
    Journal Article
  14. 14

    Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine by Ghosal, Anima, Yuan, Yuan, Hapangama, Neil, Su, Ai Duen (Iris), Alvarez, Narciso, Chowdhury, Swapan K., Alton, Kevin B., Patrick, James E., Zbaida, Shmuel

    Published in Biopharmaceutics & drug disposition (01-09-2004)
    “…Desloratadine is a non‐sedating antihistamine recently approved for the treatment of seasonal allergic rhinitis. The major metabolite of desloratadine in human…”
    Get full text
    Journal Article
  15. 15

    Quantitation of Parent Drug and Its Unstable Metabolites by in Situ Coulometric Oxidation and Liquid Chromatography−Tandem Mass Spectrometry by Tong, Wei, Chowdhury, Swapan K, Su, Ai-Duen, Alton, Kevin B

    Published in Analytical chemistry (Washington) (15-12-2010)
    “…Recent FDA and ICH guidances on safety testing of drug metabolites have challenged the way we traditionally think about quantitative bioanalytical methods…”
    Get full text
    Journal Article
  16. 16

    Identification of Two Novel Metabolites of SCH 486757, a Nociceptin/Orphanin FQ Peptide Receptor Agonist, in Humans by PENNER, Natalia A, HO, Ginny, BERCOVICI, Ana, CHOWDHURY, Swapan K, ALTON, Kevin B

    Published in Drug metabolism and disposition (01-11-2010)
    “…The study of human metabolism of endo-8[bis(2-chlorophenyl)methyl]-3-(2-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol (SCH 486757) after a 200-mg oral dose of the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Identification of unstable metabolites of Lonafarnib using liquid chromatography-quadrupole time-of-flight mass spectrometry, stable isotope incorporation and ion source temperature alteration by Tong, Wei, Chowdhury, Swapan K., Su, Ai-Duen, Feng, Wenqing, Ghosal, Anima, Alton, Kevin B.

    Published in Journal of mass spectrometry. (01-11-2006)
    “…Structural characterization of unstable metabolites and other drug‐derived entities poses a serious challenge to the analytical chemist using instrumentation…”
    Get full text
    Journal Article